1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final results of a randomized, phase III study of rituximab with or without idelalisib followed by open-label idelalisib in patients with relapsed chronic lymphocytic leukemia
    Journal Article

    Sharman, J. P.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • CAR T-cell therapy: Full speed ahead
    Conference Paper

    Sermer, D.; Brentjens, R.
    Wiley Blackwell (2019)

    Fulltext@MSK | Save
  • New drugs for new targets in lymphoma
    Review

    Younes, A.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Novel agents may positively impact chemotherapy and transplantation in subsets of diffuse large B-cell lymphoma
    Review

    Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Lazarus, H. M.
    Expert Review of Hematology (2019)

    Fulltext@MSK | Save
  • A novel paradigm between leukocytosis, G-CSF secretion, neutrophil-to-lymphocyte ratio, myeloid-derived suppressor cells, and prognosis in non-small cell lung cancer
    Journal Article

    Tavakkoli, M.; Wilkins, C. R.; Mones, J. V.; Mauro, M. J.
    Frontiers in Oncology (2019)

    Fulltext@MSK | Save
  • Cardiovascular complications associated with mediastinal radiation
    Review

    Lee Chuy, K.; Nahhas, O.; Dominic, P.; Lopez, C.; Tonorezos, E.; Sidlow, R.; Straus, D.; Gupta, D.
    Current Treatment Options in Cardiovascular Medicine (2019)

    Fulltext@MSK | Save
  • Hematopoietic-cell transplantation for lymphoma in the era of genetically engineered cellular therapy: It's not quite time to scrap the old vehicle for the new car
    Review

    Scordo, M.; Lin, R. J.; Sauter, C. S.
    Current Opinion in Hematology (2019)

    Fulltext@MSK | Save
  • Using genomic data for selecting the treatment of lymphoma patients
    Review

    Batlevi, C. L.; Shah, G.; Forlenza, C.; Intlekofer, A.
    Current Opinion in Hematology (2019)

    Fulltext@MSK | Save
  • About face: Molecular aberrations in head and neck mucosal melanomas
    Editorial

    Shoushtari, A. N.
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Can exercise-induced modulation of the tumor physiologic microenvironment improve antitumor immunity?
    Review

    Zhang, X.; Ashcraft, K. A.; Warner, A. B.; Nair, S. K.; Dewhirst, M. W.
    Cancer Research (2019)

    Fulltext@MSK | Save